Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Gov’t Consults May Be Pricey, But They Speed Review Times – Japan Officials

This article was originally published in The Gray Sheet

Executive Summary

U.S. companies should take advantage of Japan's review consultation program to speed device approval and avoid unnecessary duplication of clinical trials, top Japanese device reviewers advise
Advertisement

Related Content

Manufacturers Negotiate With Japan For Higher User Fees To Speed Review
FDA Diagnostics Office Gives Firms Advice To Improve Pre-Trial Meetings
FDA Diagnostics Office Gives Firms Advice To Improve Pre-Trial Meetings
Advertisement
UsernamePublicRestriction

Register

MT026592

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel